PharmPool
Drug Therapy Management with Adverse Reaction Control
Company Overview
Snapshot
Founded in April 2015, PharmPool operates with 1–10 employees. The company has raised a total of $50K across one funding round from 8200EISP. PharmPool focuses on drug therapy management and adverse reaction control.
Business overview
PharmPool develops an mHealth mobile application designed to enhance patient adherence and ensure safer drug therapies by managing drug interactions and adverse reactions. Its proprietary algorithm assesses drug therapy suitability based on a patient's clinical background, integrating alerts for drug interactions, disease-specific drug alerts, and vital sign anomalies. The company also provides pharmacovigilance insights by analyzing user data on medication and disease interactions, alongside marketing analytics for pharmaceutical products. PharmPool primarily serves pharmaceutical companies seeking intelligence and analytics on their products, operating within the Digital Healthcare and Patient Engagement sectors.
Log in to access full profile ›Company Intelligence Q&A
- What is PharmPool's core product?
- PharmPool's core product is MedsKeeper, an mHealth mobile application designed to help patients manage drug therapies and reduce the risk of adverse reactions by increasing adherence and ensuring safer treatment plans.
- When was PharmPool founded?
- PharmPool was founded in April 2015.
- What is PharmPool's primary business model?
- PharmPool operates with B2C and B2B2C business models, targeting both individual patients and pharmaceutical companies.
- Which markets does PharmPool target?
- PharmPool targets geomarkets including the United States, United Kingdom, Australia, and Europe.
- What technology does PharmPool utilize?
- PharmPool utilizes artificial intelligence and mobile platforms to power its drug therapy management solutions.